Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase

Autor:	Khaldun Obeidat, Arwa Alsaud, Amr Ashour, Bahjat Azrieh, Mohammad Abu-Tineh, Shehab Fareed Mohamed, Mohamed A. Yassin
Jazyk:	angličtina
Rok vydání:	2019
Předmět:	chronic myeloid leukemia imatinib side effects tremor tyrosine kinases Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Case Reports in Oncology, Vol 12, Iss 3, Pp 913-917 (2019)
Druh dokumentu:	article
ISSN:	1662-6575
DOI:	10.1159/000504937
Popis:	Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by three phases: chronic, accelerated, and blast phase. However; first- and second-generation tyrosine kinase inhibitors are used for the treatment of CML with common and uncommon adverse events. Here, we report a 24-year-old male with CML in chronic phase started on imatinib as upfront medication who developed tremor and recovered spontenously after 3 years.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/083d333feee34c5797bc1e93cb1f659e Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.